ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2204

Interosseous Tendon Inflammation in the Hands: A Novel Feature of Developing Rheumatoid Arthritis? Results from a Large MRI Study in Clinically Suspect Arthralgia

Bastiaan van Dijk1, Hanna van Steenbergen1, Monique Reijnierse2, Sarah J.H. Khidir2, Lambertus Wisse1, Marco deRuiter1 and Annette van der Helm-van Mil3, 1Leiden University Medical Centre (LUMC), Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Leiden University Medical Center, Erasmus Medical Center, Leiden, Netherlands

Meeting: ACR Convergence 2022

Keywords: Epidemiology, hand, Magnetic resonance imaging (MRI), prognostic factors, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Imaging of Rheumatic Diseases

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Inflammation around the tendons of hand interosseous muscles (interosseous tendon inflammation; ITI) on MRI was recently reported for the first time in rheumatoid arthritis (RA)-patients and ACPA-positive at-risk individuals, generating the hypothesis that ITI precedes clinical arthritis. To better understand the role of ITI during RA-development, we compared the frequency of ITI in clinically suspect arthralgia (CSA) to the general population and investigated the relation of ITI with other locally inflamed tissues (synovitis/tenosynovitis/osteitis), symptoms and future arthritis development.

Methods: 667 consecutive patients presenting with CSA and 193 symptom-free controls from the general population underwent contrast-enhanced hand-MRI. MRIs were evaluated for ITI at the ulnar and radial sides of MCP2-5, and for synovitis/tenosynovitis/osteitis using the rheumatoid arthritis MRI scoring system (RAMRIS). CSA-patients were followed on clinical arthritis development (median follow-up 25 months). Logistic and Cox-regression were used. ACPA-stratification was performed.

Results: At presentation, 10% of CSA-patients had ITI, compared to 1% of symptom-free controls (p < 0.001). ITI was more frequent in ACPA-positive than ACPA-negative CSA (27% versus 7%; p < 0.001). Synovitis and tenosynovitis at MCPs associated independently with ITI-presence (OR 2.2 (95%CI 1.2-4.2) and 9.7 (5.5-17.0), respectively). 3D MRI-reconstruction indicated that ITI is continuous with MCP flexor tenosynovitis (Figure). Although CSA-patients with ITI more often had local MCP-tenderness(1.6(1.03-2.4)), difficulties making a fist(1.6(0.98-2.7)) and reduced hand-functioning(β 0.20(0.05-0.36)), multivariable analyses showed that these symptoms were explained by co-occurring (teno)synovitis. CSA-patients with ITI developed clinical arthritis more frequently than those without (HR 4.5 (2.8-7.2)); this relation was stronger in ACPA-negative (3.9 (1.9-7.9)) than ACPA-positive CSA (1.8 (0.9-3.4)).

Conclusion: ITI is almost absent in the general population but occurs in CSA, where it precedes clinical arthritis. The strong relation with tenosynovitis evokes the question whether ITI represents true peritendonitis or juxta-articular synovial inflammation.

Supporting image 1


Disclosures: B. van Dijk, None; H. van Steenbergen, None; M. Reijnierse, ASAS, International Skeletal Society; S. Khidir, None; L. Wisse, None; M. deRuiter, None; A. van der Helm-van Mil, None.

To cite this abstract in AMA style:

van Dijk B, van Steenbergen H, Reijnierse M, Khidir S, Wisse L, deRuiter M, van der Helm-van Mil A. Interosseous Tendon Inflammation in the Hands: A Novel Feature of Developing Rheumatoid Arthritis? Results from a Large MRI Study in Clinically Suspect Arthralgia [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/interosseous-tendon-inflammation-in-the-hands-a-novel-feature-of-developing-rheumatoid-arthritis-results-from-a-large-mri-study-in-clinically-suspect-arthralgia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interosseous-tendon-inflammation-in-the-hands-a-novel-feature-of-developing-rheumatoid-arthritis-results-from-a-large-mri-study-in-clinically-suspect-arthralgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology